Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.

O'Halloran JA, Ko ER, Anstrom KJ, Kedar E, McCarthy MW, Panettieri RA, Maillo M, Nunez PS, Lachiewicz AM, Gonzalez C, Smith PB, de Tai SM, Khan A, Lora AJM, Salathe M, Capo G, Gonzalez DR, Patterson TF, Palma C, Ariza H, Lima MP, Blamoun J, Nannini EC, Sprinz E, Mykietiuk A, Alicic R, Rauseo AM, Wolfe CR, Witting B, Wang JP, Parra-Rodriguez L, Der T, Willsey K, Wen J, Silverstein A, O'Brien SM, Al-Khalidi HR, Maldonado MA, Melsheimer R, Ferguson WG, McNulty SE, Zakroysky P, Halabi S, Benjamin DK, Butler S, Atkinson JC, Adam SJ, Chang S, LaVange L, Proschan M, Bozzette SA, Powderly WG, ACTIV-1 IM Study Group Members.

Open source

DOI
10.1001/jama.2023.11043
Published
2023-07-01
Container
JAMA
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2023.11043,
  title = {Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.},
  author = {O'Halloran JA and  Ko ER and  Anstrom KJ and  Kedar E and  McCarthy MW and  Panettieri RA and  Maillo M and  Nunez PS and  Lachiewicz AM and  Gonzalez C and  Smith PB and  de Tai SM and  Khan A and  Lora AJM and  Salathe M and  Capo G and  Gonzalez DR and  Patterson TF and  Palma C and  Ariza H and  Lima MP and  Blamoun J and  Nannini EC and  Sprinz E and  Mykietiuk A and  Alicic R and  Rauseo AM and  Wolfe CR and  Witting B and  Wang JP and  Parra-Rodriguez L and  Der T and  Willsey K and  Wen J and  Silverstein A and  O'Brien SM and  Al-Khalidi HR and  Maldonado MA and  Melsheimer R and  Ferguson WG and  McNulty SE and  Zakroysky P and  Halabi S and  Benjamin DK and  Butler S and  Atkinson JC and  Adam SJ and  Chang S and  LaVange L and  Proschan M and  Bozzette SA and  Powderly WG and  ACTIV-1 IM Study Group Members.},
  year = {2023},
  journal = {JAMA},
  doi = {10.1001/jama.2023.11043},
  url = {https://doi.org/10.1001/jama.2023.11043}
}

RIS

TY  - JOUR
TI  - Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
AU  - O'Halloran JA
AU  -  Ko ER
AU  -  Anstrom KJ
AU  -  Kedar E
AU  -  McCarthy MW
AU  -  Panettieri RA
AU  -  Maillo M
AU  -  Nunez PS
AU  -  Lachiewicz AM
AU  -  Gonzalez C
AU  -  Smith PB
AU  -  de Tai SM
AU  -  Khan A
AU  -  Lora AJM
AU  -  Salathe M
AU  -  Capo G
AU  -  Gonzalez DR
AU  -  Patterson TF
AU  -  Palma C
AU  -  Ariza H
AU  -  Lima MP
AU  -  Blamoun J
AU  -  Nannini EC
AU  -  Sprinz E
AU  -  Mykietiuk A
AU  -  Alicic R
AU  -  Rauseo AM
AU  -  Wolfe CR
AU  -  Witting B
AU  -  Wang JP
AU  -  Parra-Rodriguez L
AU  -  Der T
AU  -  Willsey K
AU  -  Wen J
AU  -  Silverstein A
AU  -  O'Brien SM
AU  -  Al-Khalidi HR
AU  -  Maldonado MA
AU  -  Melsheimer R
AU  -  Ferguson WG
AU  -  McNulty SE
AU  -  Zakroysky P
AU  -  Halabi S
AU  -  Benjamin DK
AU  -  Butler S
AU  -  Atkinson JC
AU  -  Adam SJ
AU  -  Chang S
AU  -  LaVange L
AU  -  Proschan M
AU  -  Bozzette SA
AU  -  Powderly WG
AU  -  ACTIV-1 IM Study Group Members.
PY  - 2023
JO  - JAMA
DO  - 10.1001/jama.2023.11043
UR  - https://doi.org/10.1001/jama.2023.11043
ER  -

APA

JA, O., ER, K., KJ, A., E, K., MW, M., RA, P., M, M., PS, N., AM, L., C, G., PB, S., SM, D. T., A, K., AJM, L., M, S., G, C., DR, G., TF, P., C, P., H, A., MP, L., J, B., EC, N., E, S., A, M., R, A., AM, R., CR, W., B, W., JP, W., L, P., T, D., K, W., J, W., A, S., SM, O., HR, A., MA, M., R, M., WG, F., SE, M., P, Z., S, H., DK, B., S, B., JC, A., SJ, A., S, C., L, L., M, P., SA, B., WG, P., & Members., A. I. S. G. (2023). Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.. JAMA. https://doi.org/10.1001/jama.2023.11043

Source records